Stada
STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases
December 18, 2025Research and Development Bio-Thera, Immunology, Stada
STADA and Bio-Thera’s Gotenfia (golimumab), a biosimilar of Janssen’s Simponi, has received a positive opinion from the European Medicines Agency …
STADA appoints Ole Wendler Pedersen as Executive VP Legal and General Counsel
December 8, 2025Executive VP Legal and General Counsel, Stada
German pharmaceutical company STADA has announced the appointment of Ole Wendler Pedersen as its new Executive Vice President Legal and …
Takeda to jettison non-core asset portfolio to Stada for $660 million
November 6, 2019Research and Development, Sales and Marketing Stada, Takeda, pharma
Takeda has announced it is divesting a portfolio of its over-the-counter (OTC) and prescription drug products to Stada for a …
Stada poaches Novartis exec for fifth CEO in two years
February 8, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Stada, appointment
Stada has revealed its new CEO as Peter Goldschmidt, the current head of North American operations at Novartis’ generics and …
Stada takeover back in motion after revised bid
July 12, 2017Research and Development Bain capital, Cinven, Stada, biotech, drugs, generics, pharma, pharmaceutical
Stada, the German generic manufacturer, has had a particularly protracted takeover journey to reach a point, now, where it looks …
Stada CEO and CFO tumble in takeover turmoil
July 4, 2017Sales and Marketing Bain capital, Cinven, Stada
Stada, the German generic drugs manufacturer, saw its two most senior executives leave the company for ‘personal reasons’. Matthias Wiedenfels, …
Stada encourages bidding war, with figure of €3.5 billion mooted
February 15, 2017Research and Development, Sales and Marketing Advent International, Cinven, Stada
Stada, the German generic drugmaker, has received two offers for takeover, with one estimated to be €3.5 billion, thought to …
Grunenthal in talks to sell pain drug portfolio
May 19, 2011Sales and Marketing Grunenthal, Stada, chronic pain, pain therapeutics
Grunenthal is negotiating a 360 million euro deal to sell Central and Eastern European rights to some of its pain …
